Marathi
|
Hindi
Download App
Epaper
Home
City
Latest News
Cricket
LT Premium
National
International
Maharashtra
Opinions
Chhatrapati Sambhajinagar
Nagpur
Entertainment
Photos
Business
Technology
Sports
Lifestyle
Social Viral
Lokmat Games
Health
City
Home
Latest News
Cricket
LT Premium
National
International
Maharashtra
Opinions
Nagpur
Chhatrapati Sambhajinagar
Trending Topics :
Lok Sabha Election 2024
Ram Navami 2024
Dubai Rains
Maharashtra Lok Sabha Election
IPL 2024
Salman Khan
All
News
Photos
Videos
Alok Malik
FOLLOW
Alok malik, Latest News
Business :
Glenmark launches injection for prevention of chemotherapy-induced nausea, vomiting in India
Glenmark Pharmaceuticals on Monday said it was the first pharmaceutical firm to launch in India an intravenous injection formulation, ... ...
Business :
Glenmark launches drug for treating type 2 diabetes
Glenmark Pharmaceuticals has launched the first triple fixed-dose combination (FDC) Teneligliptin with Pioglitazone and Metformin in India for treating ... ...
Business :
Glenmark launches 'Hello Skin' - India's first Whatsapp based chatbot to help patients suffering from fungal infections
Glenmark Pharmaceuticals Ltd (Glenmark), an innovation-led global pharmaceutical company, has developed a digital patient education tool, 'Hello Skin' in collaboration with the IADVL (Indian Association of Dermatologists, Venereologists and Leprologi ...
Business :
Glenmark becomes the First Pharmaceutical Company to launch Teneligliptin + Pioglitazone Fixed-Dose Combination Drug for Type 2 Diabetes in India
Glenmark Pharmaceuticals Limited (Glenmark), an innovation-driven global pharmaceutical company has launched a novel fixed-dose combination (FDC) of a widely used DPP4 inhibitor (Dipeptidyl Peptidase 4 inhibitor), Teneligliptin, with Pioglitazone. Th ...
Business :
Glenmark becomes the first company to launch Remogliflozin + Vildagliptin + Metformin fixed dose combination, at an affordable price for adults with Type 2 Diabetes in India
Glenmark Pharmaceuticals Limited (Glenmark), a research-led global pharmaceutical company has launched a fixed-dose combination (FDC) of its novel, patent-protected, globally researched Sodium-Glucose Co-Transporter Inhibitor (SGLT2i) - Remogliflozin ...
Health :
Glenmark launches diabetic drug
Chennai, Oct 26 Pharma major Glenmark Pharmaceuticals Limited on Tuesday said it has launched a fixed dose combination ... ...
Health :
Glenmark Pharmaceuticals launches fixed-drug combination for management of type 2 diabetes
Glenmark Pharmaceuticals Limited (Glenmark), a research-led global pharmaceutical company has launched a fixed drug combination for the management of type 2 diabetes. ...
Business :
Glenmark concludes post marketing surveillance (PMS) study on Favipiravir (FabiFlu®)
Glenmark Pharmaceuticals, a research-led, global integrated pharmaceutical company, today announced the successful completion of its Post Marketing Surveillance (PMS) study on Favipiravir (FabiFlu®) in India. ...
Next Page